CKD-504

DB18235InvestigationalSmall molecule

CKD-504 is a novel, selective histone deacetylase 6 inhibitor.

Mechanism: Pharmacologically active on Protein deacetylase HDAC6
Curator reviewed
Code names: CKD 504

Resolves to

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with CKD-504, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.